TE_99
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | SVA_E |
|---|---|
| TE superfamily | SVA |
| TE class | Retroposon |
| Gene | LZIC |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.43 |
| Counts of samples | TCGA_tumor:100; TCGA_normal:7; GTEx:254 |
| TSS | chr1(-):9937487 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_99.1 | LZIC | Chimeric | Non-coding | Non-coding | chr1(-):9930437,9930457,9931891,9931972,9932803,9932898,9934762,9934860,9935492,9935627,9936519,9936627,9937420,9937488 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
